Elamipretide for Barth Syndrome Survives FDA Advisory Vote
FDA advisors indicated a possible path forward for elamipretide as a treatment for Barth syndrome despite the lack of definitive ...
Day: October 11, 2024
Kate Middleton’s Post-Chemo Debut; CDC Probes Cancer Cluster; 15M Adults Have ADHD
Note that some links may require registration or subscription. Kate Middleton, the Princess of Wales, made her first public appearance ...
Metabolic-Bariatric Surgery Reduces Pancreatic Cancer Risk
Metabolic-bariatric surgery (MBS) appears to lower the risk for pancreatic cancer in people with obesity, with a potentially greater effect ...
MMR/MSI Testing for CRC Climbs, But Variations Persist
TOPLINE:Testing for mismatch repair (MMR) and microsatellite instability (MSI) among patients with colorectal cancer (CRC) increased from 22.7% in 2012 ...
Smartphone Data Flag Early Dementia Risk in Older Adults
Older adults at risk for dementia can be identified using mobile data obtained during a wayfinding task, a novel real-world ...
Poppy seed brew causes morphine overdose, alerting lawmakers
It sounds like a joke: poppy seeds infused with opioids.Indeed, it was a plotline on the sitcom Seinfeld. But for ...
New Scanner Creates 3D Images of Blood Vessels in Seconds
A new scanner can provide three-dimensional (3D) photoacoustic images of millimeter-scale veins and arteries in seconds.The scanner, developed by researchers ...
Substance Use Screening More Common in Marginalized Teens
TOPLINE:Injured adolescents who present at trauma centers who are Black, American Indian, or Hispanic are more likely to undergo screening ...
Benefit of Screening Colonoscopy Underestimated in NordICC
TOPLINE:Delayed reporting of cancer diagnosis by registries probably led to the weaker-than-expected effects of screening colonoscopy in preventing colorectal cancer ...
Time to Revisit Off-Label COMT Use?
PHILADELPHIA — Early adjuvant use of opicapone (Ongentys) may reduce the risk for complications in patients with early Parkinson's disease ...
New Gynecology Trials: Could Your Patient Benefit?
Several new studies on gynecologic conditions have started in recent months. Perhaps one of your patients would be interested?Human papillomavirus ...
Early Promise for Vaccine in Parkinson’s and MSA
PHILADELPHIA — The experimental vaccine UB-312 shows early promise in Parkinson's disease (PD) and multiple system atrophy (MSA), results of ...
IV Fluids in Short Supply as Hurricanes Affect Drugmakers
Oct. 10, 2024 — A clear bag of liquid hanging next to a hospital bed typically doesn't warrant a second ...
Ready for a Jolt? Caffeine Brings Benefits and Risks
Coffee and tea are among the plants that are highest in caffeine. Their use as beverages makes caffeine the most ...
Live Rotavirus Vax Safe for Babies of Biologic-Treated Moms
More evidence suggests there is little risk in administering the live rotavirus vaccine to the babies of mothers on biologics ...
New Treatment Effective for Male Postpartum Depression
A psychosocial intervention designed to improve depressive symptoms and promote good parenting skills can be an effective way of treating ...
The Lingering Fatigue of COVID-19
TOPLINE:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was linked to an overall 3% increase in self-reported fatigue and a ...
The ‘Enormous’ Promise of Focused Ultrasound Now Coming True
After several years of investigating focused ultrasound as a tool in treating Alzheimer's, the field took a big leap forward ...
Physician Empathy Mitigates Patients’ Chronic Pain
Physicians who treat patients are potentially exposed to two opposing psychological processes: A positive feeling related to the experience of ...
FDA Approves Inavolisib for PIK3CA-Mutated HR+/HER2− MBC
The US Food and Drug Administration (FDA) has approved inavolisib (Itovebi, Genentech) in combination with palbociclib and fulvestrant for endocrine-resistant, ...
